Synthego co-founder Paul Dabrowski is coming to Disrupt New York 2017

 Genetic engineering startup Synthego makes synthetic ribonucleic acid (RNA), an important genetic component found in all living cells and also used in CRISPR Cas9, a technology enabling scientists to rip out unwanted genetic code with scissor-like precision. The company was founded four years ago by brothers Paul and Michael Dabrowski. The two left SpaceX where they both worked as rocket… Read More

http://ift.tt/2p43BB5 Synthego co-founder Paul Dabrowski is coming to Disrupt New York 2017 http://ift.tt/2plpHzg